RuthMO'ReganMD

Clinical Trials

• Docetaxel Followed by Capecitabine Versus Concomitant Docetaxel/Capecitabine for Early Stage Breast Cancer Start of enrollment: 2006 Dec 01

  Unknown status

  Phase 2

• Trial Using Docetaxel Cytoxan in Breast Cancers With High Recurrence Scores Start of enrollment: 2009 Apr 01

  Terminated

  Phase 2

• Phase II Trial of EVEROLIMUS ± Trastuzumab in Hormone-Refractory Metastatic Breast Cancer Start of enrollment: 2009 May 01

  Completed

  Phase 2

• Re-expression of ER in Triple Negative Breast Cancers Start of enrollment: 2010 Jul 01

  Terminated

  Phase 1, Phase 2

• Early Surgery or Standard Palliative Therapy in Treating Patients With Stage IV Breast Cancer Start of enrollment: 2011 May 16

  Completed

  Not Applicable

• Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer Start of enrollment: 2011 Jan 15

  Active, not recruiting

  Phase 3

• A Study of the Experimental Drug BKM120 With Paclitaxel in Patients With HER2 Negative, Locally Advanced or Metastatic Breast Cancer, With or Without PI3K Activation Start of enrollment: 2012 Aug 01

  Completed

  Phase 2, Phase 3

• A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi Start of enrollment: 2012 Oct 03

  Terminated

  Phase 3

• Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women Start of enrollment: 2014 Mar 11

  Completed

  Phase 2

• Exemestane With or Without Entinostat in Treating Patients With Recurrent Hormone Receptor-Positive Breast Cancer That is Locally Advanced or Metastatic Start of enrollment: 2014 Mar 29

  Active, not recruiting

  Phase 3

• Study of Efficacy of Ribociclib After Progression on CDK4/6 Inhibition in Patients With HR+ HER2- Advanced Breast Cancer Start of enrollment: 2016 Mar 01

  Active, not recruiting

  Phase 2

• Ribociclib and Bicalutamide in AR+ TNBC Start of enrollment: 2018 May 07

  Recruiting

  Phase 1, Phase 2

• ONC201 With a Methionine-Restricted Diet in Patients With Metastatic Triple Negative Breast Cancer Start of enrollment: 2018 Nov 13

  Terminated

  Phase 2

• Join now to see all